Global Prenatal Genetic Testing—Forecast to 2026

Global Prenatal Genetic Testing—Forecast to 2026

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

RELEASE DATE
03-Oct-2022
REGION
Global
Research Code: K7E9-01-00-00-00
SKU: HC03591-GL-MT_26963
$4,950.00
In stock
SKU
HC03591-GL-MT_26963
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow.

The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies.

The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Prenatal Genetic Testing

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Segmentation

Competitive Landscape: Regional Snapshot

Growth Metrics

Growth Drivers

Growth Restraints

Global Impact of Changes in the US Abortion Law

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Type of Test

Revenue Forecast by Type of Test (continued)

Revenue Forecast by Type of Test (continued)

Revenue Forecast by Region

Revenue Forecast Analysis

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

NIPT Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Carrier Screening Test Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Invasive Tests Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Miscarriage Test Market Overview

Growth Metrics

Revenue Forecast

Forecast Analysis

Growth Opportunity 1: eCommerce and Direct-to-consumer Sales

Growth Opportunity 1: eCommerce and Direct-to-consumer Sales (continued)

Growth Opportunity 2: Technological Advancement and Low-Cost Solutions 

Growth Opportunity 2: Technological Advancement and Low-Cost Solutions (continued)

Growth Opportunity 3: Partnerships and Joint Ventures

Growth Opportunity 3: Partnerships and Joint Ventures (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help prenatal genetic testing providers understand the key trends emerging in the market (for the various prenatal tests offered in different geographic regions). It provides information on the state of the market and estimates its growth for the next 5 years, and it lists the unmet needs that companies must work on for their continuous growth. In addition, the study provides an overview of the major vendors offering tests, their market concentration, and different growth strategies. The research service guides prenatal genetic testing providers in mapping strategic priorities and developing new capabilities to capitalize on emerging growth opportunities in this market based on current and expected numbers.
More Information
Author Lucila Martin
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number K7E9-01-00-00-00